Page last updated: 2024-09-04

glucagon and brl 26830a

glucagon has been researched along with brl 26830a in 2 studies

Compound Research Comparison

Studies
(glucagon)
Trials
(glucagon)
Recent Studies (post-2010)
(glucagon)
Studies
(brl 26830a)
Trials
(brl 26830a)
Recent Studies (post-2010) (brl 26830a)
26,0391,4983,0543950

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yoshida, T1
Hiraoka, N; Kondo, M; Yoshida, T1

Other Studies

2 other study(ies) available for glucagon and brl 26830a

ArticleYear
The antidiabetic beta 3-adrenoceptor agonist BRL 26830A works by release of endogenous insulin.
    The American journal of clinical nutrition, 1992, Volume: 55, Issue:1 Suppl

    Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dogs; Ethanolamines; Female; Glucagon; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred ICR; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta

1992
Effects of a beta 3-adrenoceptor agonist, BRL 26830A, on insulin and glucagon release in mice.
    Endocrinologia japonica, 1991, Volume: 38, Issue:6

    Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Ethanolamines; Female; Glucagon; Insulin; Islets of Langerhans; Mice; Mice, Inbred ICR; Receptors, Adrenergic, beta; Streptozocin; Time Factors

1991